Nigeria There are indications that Nigeria is in the process of obtaining the US FDA-approved coronavirus treatment drug, remdesivir, for use on patients in the country, according to Chikwe Ihekweazu, the director-general of the Nigeria Centre for Disease Control (NCDC).
The US Food and Drug Administration (FDA) authorised emergency use of the Ebola drug, remdesivir, for treating the coronavirus Friday, after a clinical trial showed patients on the drug recovered 31 percent faster than those on a placebo. That translates to shaving four days off the typical hospital stay among these patients.
It is the first drug to show a clinical benefit for COVID-19 patients in a high-quality randomized study.
“It’s a victory for science as it is the first drug to show clinical evidence of efficacy,” Chikwe Ihekweazu, director-general of the NCDC, said in an interview on Channels Television, Sunday.
Source: Business Day News
